Successful HeartMate 3 LVAD implantation in a patient with active heparin-induced thrombocytopaenia with thrombosis using pre-implantation plasmapheresis and intraoperative continuous prostacyclin.
Citation: Interactive Cardiovascular & Thoracic Surgery. 33(1):161-162, 2021 06 28.PMID: 33575742Institution: MedStar Heart & Vascular InstituteForm of publication: Journal ArticleMedline article type(s): Journal ArticleSubject headings: *Heart Failure | *Heart-Assist Devices | *Thrombocytopenia | *Thrombosis | Anticoagulants/ae [Adverse Effects] | Epoprostenol | Heart Failure/th [Therapy] | Heparin/ae [Adverse Effects] | Humans | Plasmapheresis | Thrombocytopenia/ci [Chemically Induced] | Thrombocytopenia/th [Therapy] | Thrombosis/ci [Chemically Induced] | Thrombosis/dg [Diagnostic Imaging]Year: 2021ISSN:- 1569-9285
Item type | Current library | Collection | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|---|
Journal Article | MedStar Authors Catalog | Article | 33575742 | Available | 33575742 |
Heparin-induced thrombocytopaenia describes a prothrombotic state with significant rates of thrombus formation. We present a rare case of successful implantation of a HeartMate 3 left ventricular assist device in a patient with active heparin-induced thrombocytopaenia with thrombosis using preoperative plasmapheresis followed by intraoperative prostacyclin administration. Copyright (c) The Author(s) 2021. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.
English